This is the second webinar in the PCRS Maintenance and Reliever Therapy (MART) in asthma campaign.

In November 2024 the National Institute for Health and Care Excellence (NICE), in collaboration with the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN), launched their updated guideline: Asthma: diagnosis, monitoring and chronic asthma

On the 28th November the joint National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) will publish their long-awaited single guideline on asthma diagnosis, monitoring and management.

This webinar featured short presentations and discussions from our amazing and vastly experienced panel: Carol Stonham, Kevin Gruffydd-Jones, Deborah Leese, Helena Cummings and Darush Attar-Zadeh, chaired by our Executive Vice-Chair Ren Lawlor.

This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma. It is not intended to be a comprehensive guide of the new guideline, neither does it cover all non-pharmacological treatments or on-going monitoring.

Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers. 

Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.

Very Brief Advice (VBA) is our most practical tool to trigger a quit attempt, with structured behavioural support and medical treatment being the best method of quitting and ideally these are provided by stop smoking practitioners.

Tobacco dependency is a long-term relapsing condition that usually starts in childhood This tobacco dependency pragmatic guide is a practical, immediately implementable, evidence-based framework to enable healthcare professionals to routinely identify smokers, encourage a quit attempt a

People living with respiratory disease require a significant amount of support, guidance and intervention to manage their condition effectively. These interventions should be delivered by clinicians with an appropriate level of expertise in this field.

The new BTS/NICE/SIGN guideline, Asthma: Diagnosis, monitoring and chronic asthma management (NG245) has placed fractional exhaled nitric oxide (FeNO) early in the diagnostic algorithm, which has caused some concern.

PCRS are proud to have supported NHS England London’s #AskAboutAsthma campaign over the years.

This document outlines a consensus recommendation based on the best available evidence and expert opinion. Its purpose is to provide guidance on a safe approach within the limitations of the evidence and devices currently available.

Respiratory disease and mental health are interlinked in many ways, with respiratory conditions often impacting mental wellbeing and vice versa. NHS England states that people with severe and enduring mental illness are at greater risk of poor physical health and reduced life expect

People living in the most deprived communities across the country are set to benefit from new neighbourhood health services as the government takes the first steps in the rollout today (Wednesday 9th July), making care more convenient and reducing health inequalities.